BioLineRx Ltd.
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
-17.6-198-132
Price/Sales ratio
7.845.213.43
Earnings per Share (EPS)
$-0.22$-0.02$-0.03

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.16-4.64-3.26-4.06-2.58-0.81-1.37-3.20-1.61-1.66-2.19-2.58
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A21.00N/AN/A
Price/Book Value ratio
1.651.401.471.871.150.651.921.320.597.620.960.65
Price/Cash Flow ratio
-3.62-4.71-3.55-4.81-1.97-0.96-1.83-3.82-1.16-4.46-2.09-0.96
Price/Free Cash Flow ratio
-3.58-3.95-3.54-3.99-1.38-0.96-1.83-3.80-1.14-4.40-2.08-0.96
Price/Earnings Growth ratio
0.080.42-4.561.010.06-0.110.040.040.03-0.01-0.03-0.11
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A23.08%N/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-1035.29%N/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-1262.79%N/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A-1262.79%N/AN/A
Effective Tax Rate
55.77%12.47%4.24%3.64%19.40%-5.34%-3.03%-4.02%24.36%-0.00%N/AN/A
Return on Assets
-28.13%-28.06%-40.68%-39.94%-32.91%-50.04%-65.40%-34.57%-24.70%-94.82%-29.76%-32.91%
Return On Equity
-32.03%-30.24%-45.22%-46.05%-44.78%-80.30%-140.40%-41.33%-37.11%-458.39%-38.72%-44.78%
Return on Capital Employed
-47.64%-33.62%-46.80%-46.53%-51.74%-67.57%-62.55%-34.57%-44.37%-150.25%-37.38%-51.74%
Liquidity Ratios
Current Ratio
12.1015.349.867.494.732.352.15N/AN/AN/A7.124.73
Quick Ratio
12.1128.689.8614.044.732.352.155.908.721.467.054.73
Cash ratio
1.991.760.670.760.500.441.581.330.990.131.610.50
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A53.83N/AN/A
Days of Inventory outstanding
N/A-34.67KN/A-33.46KN/AN/AN/AN/A-23.00K193.07N/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A246.91N/AN/A
Days of Payables Outstanding
N/A1.58K1.96K4.18K3.63K3.02K2.31K2.89K3.88K1.07KN/A3.02K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A-827.61N/AN/A
Debt Ratios
Debt Ratio
N/A0.000.000.000.150.150.120.030.130.150.320.15
Debt Equity Ratio
N/A0.000.000.000.210.250.260.040.200.730.470.21
Long-term Debt to Capitalization
N/A0.000.000.000.150.140.11N/A0.140.330.150.14
Total Debt to Capitalization
N/A0.000.000.000.170.200.200.030.170.420.160.20
Interest Coverage Ratio
-881.7-1.07K-1.17K-1.20K-1.21K-15.17-15.59N/AN/AN/A-25.24-1.21K
Cash Flow to Debt Ratio
N/A-32.42-42.31-82.18-2.77-2.66-3.97-8.55-2.47-2.31-2.35-2.77
Company Equity Multiplier
1.131.071.111.151.361.602.141.191.504.831.471.36
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-4.71N/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.011.191.001.201.421.0011.001.011.011.001.00
Cash Flow Coverage Ratio
N/A-32.42-42.31-82.18-2.77-2.66-3.97-8.55-2.47-2.31-2.35-2.77
Short Term Coverage Ratio
N/A-152.34-156.05-220.93-27.03-8.41-7.50-8.55-13.32-7.18-26.74-27.03
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A